Larry Ellison has cancelled his plan to sell $7.5bn of Oracle stock, a day after it surfaced
Larry Ellison, Oracle's executive chair and CTO, canceled a plan to sell up to 50 million shares (worth $7.5B) by October 24. No shares were sold, and the company stated he has no further plans to sell. The shares' value dropped 16% since the plan's adoption. Oracle reported shrinking margins and increased job cut costs.
How this was made

The 30-second read
Why it matters
The cancellation eliminates a possible $7.5 bn sell‑off, reducing immediate supply risk.
Market read
First report of a major insider trading plan cancellation for a mega‑cap, relevant for equity traders and compliance monitoring.
What to watch
Potential regulatory scrutiny of 10b5‑1 plans in Europe could affect future insider trading strategies.
Background
Rule 10b5‑1 plans allow insiders to pre‑schedule trades; EU rules prohibit trading within 30 days of earnings.
Ticker impact
Oracle cancelled a Rule 10b5‑1 plan to sell up to 50 million shares (~$7.5 bn) after it was disclosed.
ORCL may see modest upside or stability as the expected supply shock is removed.
No shares were sold; the plan's removal eliminates a known future dilution risk.
Market effects
Tech sector may see reduced short‑selling pressure on large‑cap software stocks.
US markets only; no direct foreign impact.
Limited to investors tracking insider trading activity and large‑cap equity flows.
Counterpoint
Some investors may view the cancellation as a sign of confidence and increase exposure.
Key entities
- individualLarry Ellison
Executive chair and CTO of Oracle, controlling ~40% of shares.
- companyOracle Corporation
US‑listed software and cloud services provider.

